MyFinsight
Home
Blog
About
Accounts payable
$32,323K
(727.73%↑ Y/Y)
Net income
$31,500K
(-31.00%↓ Y/Y)
Accrued liabilities
$22,531K
(5.53%↑ Y/Y)
Stock-based compensation
$16,940K
(-34.14%↓ Y/Y)
Proceeds from issuance of
common stock, net of...
$10,494K
(-41.03%↓ Y/Y)
Deferred income taxes
$9,773K
something is missing
$5,074K
Inventory
-$3,897K
(-126.78%↓ Y/Y)
Amortization of intangible
assets
$2,723K
(-49.98%↓ Y/Y)
Long-term liabilities
$2,671K
(-74.54%↓ Y/Y)
Operating lease
right-of-use assets
-$2,234K
(47.55%↑ Y/Y)
Depreciation
$434K
(-1.81%↓ Y/Y)
Other assets
-$378K
(-128.94%↓ Y/Y)
Net cash provided by
operating activities
$100,781K
(19.58%↑ Y/Y)
Net cash provided by
financing activities
$10,494K
(-41.03%↓ Y/Y)
Canceled cashflow
$29,697K
Effect of exchange rate
changes on cash
$27K
(42.11%↑ Y/Y)
Net increase
(decrease) in cash, cash...
$102,773K
(257.50%↑ Y/Y)
Canceled cashflow
$8,529K
Accounts receivable, net
$15,295K
(74.48%↑ Y/Y)
Prepaid expenses and
other current assets
$9,843K
Interest and other
receivables
$2,660K
(-57.27%↓ Y/Y)
Operating lease
liabilities
-$1,849K
(-30.39%↓ Y/Y)
Amortization of premiums and
accretion of discounts on...
$50K
(-98.63%↓ Y/Y)
Maturity of investment
securities
$90,000K
(-65.67%↓ Y/Y)
Net cash provided by
(used in) investing...
-$8,529K
(94.90%↑ Y/Y)
Canceled cashflow
$90,000K
Purchases of investment
securities
$93,440K
(-71.72%↓ Y/Y)
Purchases of property and
equipment
$5,089K
(1613.47%↑ Y/Y)
Back
Back
Cash Flow
ACADIA PHARMACEUTICALS INC (ACAD)
ACADIA PHARMACEUTICALS INC (ACAD)
source: myfinsight.com